Vaxcell-Bio Therapeutics (Korea) Price History

323990 Stock  KRW 9,380  60.00  0.64%   
If you're considering investing in Vaxcell-Bio Stock, it is important to understand the factors that can impact its price. As of today, the current price of Vaxcell-Bio Therapeutics stands at 9,380, as last reported on the 25th of February, with the highest price reaching 9,380 and the lowest price hitting 9,270 during the day. Vaxcell-Bio Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.19, which indicates the firm had a -0.19 % return per unit of risk over the last 3 months. Vaxcell Bio Therapeutics Co exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vaxcell-Bio Therapeutics' Risk Adjusted Performance of (0.06), coefficient of variation of (1,057), and Variance of 6.67 to confirm the risk estimate we provide.
  
Vaxcell-Bio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1927

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns323990

Estimated Market Risk

 2.6
  actual daily
23
77% of assets are more volatile

Expected Return

 -0.5
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.19
  actual daily
0
Most of other assets perform better
Based on monthly moving average Vaxcell-Bio Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vaxcell-Bio Therapeutics by adding Vaxcell-Bio Therapeutics to a well-diversified portfolio.

Vaxcell-Bio Therapeutics Stock Price History Chart

There are several ways to analyze Vaxcell-Bio Stock price data. The simplest method is using a basic Vaxcell-Bio candlestick price chart, which shows Vaxcell-Bio Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 29, 202413200.0
Lowest PriceFebruary 20, 20259320.0

Vaxcell-Bio Therapeutics February 25, 2025 Stock Price Synopsis

Various analyses of Vaxcell-Bio Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Vaxcell-Bio Stock. It can be used to describe the percentage change in the price of Vaxcell-Bio Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Vaxcell-Bio Stock.
Vaxcell-Bio Therapeutics Price Daily Balance Of Power 0.55 
Vaxcell-Bio Therapeutics Price Action Indicator 85.00 
Vaxcell-Bio Therapeutics Price Rate Of Daily Change 1.01 

Vaxcell-Bio Therapeutics February 25, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Vaxcell-Bio Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Vaxcell-Bio Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Vaxcell-Bio Stock and then apply it to test your longer-term investment strategies against Vaxcell-Bio.

Vaxcell-Bio Stock Price History Data

The price series of Vaxcell-Bio Therapeutics for the period between Wed, Nov 27, 2024 and Tue, Feb 25, 2025 has a statistical range of 3880.0 with a coefficient of variation of 8.62. The prices are distributed with arithmetic mean of 10843.48. The median price for the last 90 days is 10720.0. The company had 2:1 stock split on 30th of December 2020.
OpenHighLowCloseVolume
02/25/2025
 9,320  9,380  9,270  9,380 
02/24/2025 9,320  9,380  9,270  9,380  86,734 
02/21/2025 9,440  9,840  9,300  9,320  264,773 
02/20/2025 9,560  9,570  9,290  9,320  153,958 
02/19/2025 9,710  9,780  9,540  9,560  160,622 
02/18/2025 9,810  9,860  9,710  9,710  88,809 
02/17/2025 9,760  9,840  9,710  9,790  79,397 
02/14/2025 9,850  9,880  9,670  9,750  136,982 
02/13/2025 9,890  10,010  9,810  9,830  106,604 
02/12/2025 10,000  10,050  9,870  9,930  73,967 
02/11/2025 10,010  10,100  9,970  10,000  67,254 
02/10/2025 9,960  10,050  9,910  10,000  72,412 
02/07/2025 10,210  10,210  10,020  10,040  82,147 
02/06/2025 10,150  10,390  10,150  10,220  46,202 
02/05/2025 10,050  10,270  10,050  10,100  70,681 
02/04/2025 10,000  10,140  10,000  10,040  56,030 
02/03/2025 10,280  10,500  9,920  9,980  185,270 
01/31/2025 10,280  10,750  10,280  10,310  59,082 
01/24/2025 10,300  10,750  10,270  10,280  96,919 
01/23/2025 10,750  10,750  10,290  10,300  118,929 
01/22/2025 10,640  10,840  10,570  10,600  125,865 
01/21/2025 11,050  12,490  10,700  10,720  936,381 
01/20/2025 10,400  10,770  10,370  10,660  88,238 
01/17/2025 10,800  10,830  10,330  10,400  79,029 
01/16/2025 10,670  10,900  10,670  10,750  48,500 
01/15/2025 11,000  11,000  10,610  10,620  79,211 
01/14/2025 11,030  11,450  10,850  10,920  95,987 
01/13/2025 10,950  11,280  10,790  10,980  130,824 
01/10/2025 11,150  11,150  10,860  10,950  47,249 
01/09/2025 10,930  11,080  10,840  11,060  59,431 
01/08/2025 11,060  11,200  10,900  10,960  74,639 
01/07/2025 11,130  11,230  10,920  10,950  70,623 
01/06/2025 10,800  11,160  10,690  11,140  97,599 
01/03/2025 10,610  10,850  10,610  10,800  75,479 
01/02/2025 10,560  10,780  10,440  10,650  79,381 
12/30/2024 10,040  10,530  10,000  10,430  92,064 
12/27/2024 10,180  10,290  9,980  10,030  76,209 
12/26/2024 10,270  10,470  10,190  10,200  63,459 
12/24/2024 10,510  10,700  10,270  10,270  67,425 
12/23/2024 10,100  10,720  10,030  10,500  144,295 
12/20/2024 10,440  10,440  10,000  10,000  136,956 
12/19/2024 10,400  10,570  10,380  10,440  100,992 
12/18/2024 10,650  10,770  10,580  10,720  94,808 
12/17/2024 11,100  11,200  10,640  10,650  208,032 
12/16/2024 11,300  11,560  10,930  10,970  185,141 
12/13/2024 10,930  11,470  10,800  11,130  307,943 
12/12/2024 11,300  11,560  10,360  10,770  939,785 
12/11/2024 11,170  11,740  11,130  11,400  98,144 
12/10/2024 10,610  11,240  10,610  11,170  84,867 
12/09/2024 11,550  11,550  10,500  10,570  219,124 
12/06/2024 12,060  12,080  11,600  11,650  124,995 
12/05/2024 12,050  12,160  11,830  11,950  62,899 
12/04/2024 12,000  12,260  12,000  12,140  111,033 
12/03/2024 12,450  12,500  12,230  12,380  62,757 
12/02/2024 13,470  13,700  12,200  12,270  340,655 
11/29/2024 12,920  13,370  12,800  13,200  178,563 
11/28/2024 12,930  13,480  12,710  12,950  126,578 
11/27/2024 12,720  12,850  12,540  12,810  65,351 
11/26/2024 12,610  12,800  12,500  12,740  61,226 
11/25/2024 12,080  12,900  12,080  12,610  96,381 
11/22/2024 11,750  12,340  11,710  12,180  100,866 

About Vaxcell-Bio Therapeutics Stock history

Vaxcell-Bio Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vaxcell-Bio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vaxcell-Bio Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vaxcell-Bio Therapeutics stock prices may prove useful in developing a viable investing in Vaxcell-Bio Therapeutics
Vaxcell-Bio Therapeutics Co., Ltd. develops and sells cancer immune cell therapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea. Vaxcell Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.

Vaxcell-Bio Therapeutics Stock Technical Analysis

Vaxcell-Bio Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Vaxcell-Bio Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Vaxcell-Bio Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Performance Analysis Now

   

Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
All  Next Launch Module

Vaxcell-Bio Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Vaxcell-Bio Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Vaxcell-Bio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vaxcell-Bio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Vaxcell-Bio Stock analysis

When running Vaxcell-Bio Therapeutics' price analysis, check to measure Vaxcell-Bio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcell-Bio Therapeutics is operating at the current time. Most of Vaxcell-Bio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vaxcell-Bio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcell-Bio Therapeutics' price. Additionally, you may evaluate how the addition of Vaxcell-Bio Therapeutics to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Commodity Directory
Find actively traded commodities issued by global exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets